Last $6.23 HKD
Change Today -0.01 / -0.16%
Volume 568.0K
2348 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for dawnrays pharmaceutical hold (2348)

Year over year, Dawnrays Pharmaceutical Holdings Ltd. has been able to grow revenues from CNY856.5M CNY to CNY915.0M CNY. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 62.13% to 55.93%. This was a driver that led to a bottom line growth from CNY114.5M CNY to CNY153.1M CNY.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2010
CNY
Dec 31
2011
CNY
Dec 31
2012
CNY
Dec 31
2013
CNY
4 Year
Trend
Revenues1,286.71,081.0856.5915.0
TOTAL REVENUES1,286.71,081.0856.5915.0
Cost of Goods Sold910.5718.3532.1511.7
GROSS PROFIT376.2362.8324.4403.2
Selling General & Admin Expenses, Total144.6156.6157.8174.4
Other Operating Expenses31.341.432.553.5
OTHER OPERATING EXPENSES, TOTAL175.9198.0190.3227.9
OPERATING INCOME200.3164.7134.1175.4
Interest Expense-0.5-2.2-3.8-3.6
Interest and Investment Income2.54.05.09.3
NET INTEREST EXPENSE1.91.81.25.7
Currency Exchange Gains (Loss)0.33.30.62.2
Other Non-Operating Income (Expenses)6.39.27.85.6
EBT, EXCLUDING UNUSUAL ITEMS208.8179.1143.7188.9
Gain (Loss) on Sale of Investments0.10.11.00.1
EBT, INCLUDING UNUSUAL ITEMS208.9179.2144.6189.0
Income Tax Expense42.032.930.135.9
Minority Interest in Earnings0.0------
Earnings from Continuing Operations166.8146.3114.5153.1
NET INCOME166.8146.3114.5153.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS166.8146.3114.5153.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS166.8146.3114.5153.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2348:HK $6.23 HKD -0.01

2348 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2348.
View Industry Companies
 

Industry Analysis

2348

Industry Average

Valuation 2348 Industry Range
Price/Earnings 25.5x
Price/Sales 4.3x
Price/Book 3.6x
Price/Cash Flow 25.7x
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAWNRAYS PHARMACEUTICAL HOLD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.